EP2004183
Masíndólsamsetning til að meðhöndla ofvirkni með athyglisbresti
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.4.2007EP published:
26.6.2013EP application number:
07727980.0
EP translation filed:
18.9.2013Grant published:
15.10.2013EPO information:
European Patent Register
Max expiry date:
10.4.2027Expiry date:
10.4.2025
Title:
MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY
Timeline
Today
11.4.2007EP application
26.6.2013EP Publication
18.9.2013Translation submitted
15.10.2013Registration published
10.4.2025Expires
Owner
Name:
NLS-1 Pharma AGAddress:
Alter Postplatz 2, 6370, Stans, CH
Inventor
Name:
KONOFAL, EricAddress:
Senlis, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0603197Date:
11.4.2006Country:
FR
Classification
Categories:
A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 23.4.2014
Expires: 10.4.2015
Payer: Árnason Faktor
Number: 9
Paid: 27.4.2015
Expires: 10.4.2016
Payer: Árnason Faktor
Number: 10
Paid: 22.4.2016
Expires: 10.4.2017
Payer: Árnason Faktor
Number: 11
Paid: 25.4.2017
Expires: 10.4.2018
Payer: Árnason Faktor
Number: 12
Paid: 5.3.2018
Expires: 10.4.2019
Payer: Árnason Faktor
Number: 13
Paid: 8.3.2019
Expires: 10.4.2020
Payer: Árnason Faktor
Number: 14
Paid: 10.3.2020
Expires: 10.4.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 10.3.2021
Expires: 10.4.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 10.3.2022
Expires: 10.4.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 8.3.2023
Expires: 10.4.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 7.3.2024
Expires: 10.4.2025
Payer: Árnason Faktor ehf.